Link: https://links.sgx.com/1.0.0/corporate-announcements/T0JG20557CEFTRWA/e1c219dd674895904a26e129493e1f307ed90d67c34dc246fe017139c628450b

Summary:

• Group revenue decreased by 15% to S$1.16 million, mainly due to reduced contribution from a relocated clinic and a veterinarian on maternity leave.

• Gross profit was S$0.32 million with a margin of 27.6%, down from S$0.45 million and 33.1% in 1H 2024.

• Net loss for 1H 2025 widened to S$4.33 million, from a S$0.16 million loss in 1H 2024, due mainly to a S$4 million goodwill impairment.

• Administrative expenses fell slightly to S$0.80 million, while other operating income dropped 27% to S$0.16 million.

• Cash and cash equivalents stood at S$8.13 million at 30 June 2025; net cash generated from operations was S$0.19 million.

• Net asset value per share as of 30 June 2025 was 7.90 cents, down from 10.86 cents at end-2024.

• No interim dividend was declared, as the board aims to conserve cash for business growth.

• The group maintains a positive working capital position and continues to upgrade operations following clinic relocations.